Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil

Salha, Leila Abou; Reis, Flávia Costa; Gonçalves, Roberta Moreira; Lima, Jordão Horácio da Silva; Salha, Nádia Abou; Pinto, Roney Pereira; de Menezes, José Elmo; Oliveira, Eduardo Perez; Ferreira, Pedro Lopes; Barbosa, Maria Alves

doi:10.1186/s12939-022-01704-6

International Journal for Equity in Health

Table 4 Correlation between study variables and service times at TJGO and TRF-Goiás

From: Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil

Variables	Service time (days)			Service time TJGO (days)			Service time TRF-Goiás (days)
Variables	Mean	Standard Deviation	p-value	Mean	Standard Deviation	p-value	Mean	Standard Deviation	p-value
Gender
Male	13.91	16.87	0.74	8.59	5.86	0.85	46.75	38.77	0,32
Female	12.92	20.02	0.74	8.78	6.12	0.85	32.35	32.12	0,32
Age
0–17	11.62	17.49	0.69	6.83	6.91	0.54	26	36.77	0,73
18–24	4.6	4.72		5.25	5.18		2	NA
25–34	16.18	24.08		9.67	6.22		35.75	45.58
35–44	11.36	16.82		7.56	4.6		55	46.67
45–54	13.76	14.58		10.35	6.85		31.17	26.64
55–64	10.94	8.7		9.29	6.07		28	14.8
65 years or older	16.79	25.7		8.17	5.81		54.5	42.46
Income
Less than 1SM	12.87	14.11	0.96	8.89	4.96	0.904	28.2	25.74	0,48
Greater than 3SM	12.89	15.09		8.14	6.58		29.5	24.19
Not Specified	13.72	20.13		8.77	6.05		46.4	41.19
Sponsorship
Public prosecutor	7.86	5.86	0*	7.9	5.87	0.06	4	NA	0,32
Public defense	26.72	29.81		11.18	6.54		40.4	35.36
Lawyer	9.25	5.33		9.25	5.53		NA	NA
Medication
temozolamide	12.7	9.93	0.245	11	5.46	0.042*	52	NA	0,121
bevacizumab	14.09	20.33		10.68	7.01		25	41.06
Rituximab	16.87	31.02		6.84	3.57		82	59.39
Pazopanib	22.56	25.51		9.5	6.22		44.33	31.2
pembrolizumab	8.7	5.47		8.7	5.47		NA	NA
ibrutinib	22.5	35.48		10.14	6.64		109	NA
pembrolizumab	8.7	5.47		8.7	5.47		NA	NA
Bortezomide	12.06	11.51		9.88	7.08		49	NA
Others	9.84	12.48		6.34	5.26		24.9	21.44
ICD-10
C-90	14.3	12.4	0.0388	10.88	6.83	0.015	45	5.66	0,276
C-71	12.73	10.15		10.95	5.58		52	NA
C-53	13.7	29.38		5	2.78		3454.58
C-64	18.79	19.86		9.44	6.6		35.6	25.39
C-43	13.7	29.38		5	2.78		34	54.58
C-91	34.2	44.84		9.85	6.54		91	44.8
C-18	10	9.96		10	9.96		NA	NA
C-50	20.83	12.56		15.25	8.46		32	14.14
C-81	11.85	15.24		5	1.73		17	19.49
C-82	8.25	3.77		8.25	3.77		NA	NA
Others	9.27	14.13		6.59	4.74		31.17	35.98
Origin of the report
Public	20.43	12.89	0.701	15.83	5.96	0.726	38.44	35.99	0,69
Private	10.43	12.86	0.701	7.6	6.25	0.726	53	NA	0,69
QOL justification
Yes	23.508	21.4	0.534	24.49	28.13	0.4024	7	9.18	-
No	20.69	27	0.534	20.69	21.4	0.4024	NA	NA	-

^*p-value < 0.05

Back to article page

ISSN: 1475-9276

Contact us

General enquiries: journalsubmissions@springernature.com